Related Experiment Video
Updated: Jun 28, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Current concepts in the evaluation and management of erectile dysfunction
Pamela Ellsworth1, Eileen M Kirshenbaum
1Brown University, Providence, RI, USA.
This article reviews the latest advancements in erectile dysfunction (ED) treatment, focusing on updated guidelines and oral phosphodiesterase-5 (PDE-5) inhibitors for improved patient care.
Area of Science:
- Urology
- Andrology
- Men's Health
Background:
- Erectile dysfunction (ED) is a prevalent condition affecting numerous men.
- The management of ED is continually evolving with new research and clinical recommendations.
Purpose of the Study:
- To summarize recent updates in the field of erectile dysfunction.
- To highlight key changes in established clinical guidelines.
- To discuss the current role of oral phosphodiesterase-5 (PDE-5) inhibitors.
Main Methods:
- Review of updated American Urological Association (AUA) Erectile Dysfunction Guidelines.
- Analysis of the second Princeton Consensus Panel Guidelines.
- Examination of recent literature on oral PDE-5 inhibitors.
Main Results:
- The AUA and Princeton Consensus Panel have released updated recommendations for ED diagnosis and management.
- Oral PDE-5 inhibitors remain a cornerstone therapy, with ongoing research into their efficacy and safety profiles.
Conclusions:
- Clinicians should be aware of the latest guidelines for optimal erectile dysfunction patient care.
- Understanding updates on PDE-5 inhibitors is crucial for effective treatment strategies.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Nursing Evaluation
Section...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...